financetom
Business
financetom
/
Business
/
AST SpaceMobile Targets Sept. 12 for Satellite Launch
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AST SpaceMobile Targets Sept. 12 for Satellite Launch
Sep 6, 2024 12:17 PM

09:24 AM EDT, 09/04/2024 (MT Newswires) -- AST SpaceMobile ( ASTS ) said Wednesday that it plans to launch its first five BlueBird satellites on or after Sept. 12 from Cape Canaveral, Florida.

The satellite manufacturing company said the satellites will support beta testing for AT&T ( T ) and Verizon (VZ) and are designed to deliver cellular broadband directly to standard smartphones.

AST said it expects to have $440 million in cash and equivalents on a pro forma basis as of June 30, including $155 million in expected warrant exchange proceeds. The company said it has $51.5 million in additional liquidity from a senior credit facility.

Shares of AST were up more than 10% in recent Wednesday premarket activity.

Price: 32.40, Change: +2.99, Percent Change: +10.17

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Omineca Lode Gold Provides Wingdam Exploration Program Update
Omineca Lode Gold Provides Wingdam Exploration Program Update
Nov 15, 2024
12:27 PM EST, 11/15/2024 (MT Newswires) -- Omineca Mining and Metals ( OMMSF ) on Friday said road access and first drill pads have been completed and diamond drilling is underway at the Wingdam hard rock exploration project located in the Cariboo Mining District of south central British Columbia. The company plans a 10-hole. 4,000-meter, program in downstream of the...
Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B
Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B
Nov 15, 2024
12:29 PM EST, 11/15/2024 (MT Newswires) -- Barinthus Biotherapeutics ( BRNS ) on Friday reported encouraging results from its ongoing phase 2b HBV003 trial for chronic hepatitis B. The study, involving 121 participants, assessed VTP-300 in combination with a low dose of anti-PD1 antibody nivolumab, and new data shows eight participants achieved complete HBsAg loss, while two met the criteria...
Arbutus Trial of Combination Therapy for Chronic Hepatitis B Shows 'Promising' Results
Arbutus Trial of Combination Therapy for Chronic Hepatitis B Shows 'Promising' Results
Nov 15, 2024
12:27 PM EST, 11/15/2024 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said Friday new data from phase 2a trial of imdusiran followed by Barinthus Biotherapeutics' ( BRNS ) VTP-300 plus a low dose of nivolumab in chronic hepatitis B patients showed promising results. The preliminary data showed that trial participants who received the regimen experienced increased rates of HBsAg...
Update: Market Chatter: General Motors Plans to Cut 1,000 Salaried Workers
Update: Market Chatter: General Motors Plans to Cut 1,000 Salaried Workers
Nov 15, 2024
12:29 PM EST, 11/15/2024 (MT Newswires) -- (Updates with General Motors' ( GM ) comment in the second paragraph.) General Motors ( GM ) is planning to cut around 1,000 salaried positions globally in an attempt to streamline its operations, Bloomberg reported Friday, citing people familiar with the matter. In order to win in this competitive market, we need to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved